Masahiko Nishiyama

9PUBLICATIONS
26CO-AUTHORS
Nanofabrication, growth and self assemblyCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 09, 2025
FTO promotes weight gain via altering Kif1a splicing and axonal vesicle trafficking in AgRP neurons.

Daisuke Kohno, Reika Kawabata-Iwakawa, Sotaro Ichinose

|Jun 26, 2025
Unique Function in Cancer Stemness and Prognostic Significance of EMX2 in Esophageal Squamous Cell Carcinoma.

Shoichi Fumoto, Keiji Tanimoto, Takuya Noguchi

|Aug 12, 2024
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential.

Sho Sato, Takahito Miura, Aiko Ogasawara

|May 20, 2024
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.

Reika Kawabata-Iwakawa, Norihiro Iwasa, Kenichi Satoh

|Apr 03, 2021
AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.

Hideyuki Takahashi, Susumu Rokudai, Reika Kawabata-Iwakawa

|Jan 19, 2021
Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.

Tadashi Nakajima, Tommy Dharmawan, Reika Kawabata-Iwakawa

Pageof 2

Frequent Collaborators

2 joint publications

Susumu Rokudai

2 joint publications

Tadashi Nakajima

2 joint publications

Reika Kawabata-Iwakawa

2 joint publications

Yoshiaki Kaneko